WASHINGTON – Beginning on April 14, the Social Security Administration assured AARP that they will allow all claim types to be completed over the telephone. This includes Retirement, Survivors, and Auxiliary (Spouse or Child) benefits that SSA previously announced would require in-person identity proofing, in addition to Social Security Disability

WASHINGTON — Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to restructure plans announced by the U.S. Department of Health and Human Services (HHS): “As HHS moves forward, we urge the agency to prioritize essential health needs – particularly for

AARP Statement on Customer Service Updates Announced by the Social Security Administration WASHINGTON — Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement on the customer service changes announced by the Social Security Administration: This is a good first step by the Social

AARP Statement on Customer Service Changes Announced by the Social Security Administration WASHINGTON — Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to customer service changes announced by the Social Security Administration (SSA): “The Social Security Administration’s move to force

WASHINGTON—Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement related to comments about changes at the Social Security Administration (SSA): “AARP is hearing from thousands of older Americans confused and concerned about their Social Security payments, the status of Social Security field

New AARP Report: Medicare Part D Enrollees Who Reach the New $2,000 Out-of-Pocket Spending Cap Will Save Thousands Despite Premium Changes WASHINGTON — A new report out from AARP today provides additional insight into the impact of a historic new financial protection for our nation’s nearly 55 million Medicare drug